Key result
Chronic infusion of synthetic ANF (8-33) in hypertensive rats decreased blood pressure from 183 +/- 4 mmHg to 116 +/- 5 mmHg and significantly lowered plasma renin activity.
Why the study?
Does chronic infusion of synthetic ANF (8-33) reduce blood pressure in two-kidney, one-clip hypertensive rats?
Does chronic infusion of synthetic ANF (8-33) reduce blood pressure in two-kidney, one-clip hypertensive rats?
Chronic infusion of synthetic ANF (8-33) effectively lowers blood pressure, reduces plasma renin activity, and partially reverses cardiac hypertrophy in a rat model of renovascular hypertension.
Answers are grounded in this paper and cite their sources.
ANF infusion may lower BP in renovascular hypertension models; leaves open translation to human therapy.
Conscious two-kidney, one-clip hypertensive rats were chronically infused during 7 days with synthetic ANF (8-33) (1 microgram/hr/rat) by means of osmotic minipumps. The initial blood pressure of 183 +/- 4 mmHg gradually decreased to 116 +/- 5 mmHg the last 2 days of infusion. Pressure diuresis returned to normal and pressure natriuresis was attenuated. PRA was significantly lower (1.81 +/- 0.41 AI ng/ml/hr) than in not treated hypertensive rats (8.56 +/- 3.75 AI ng/ml/hr). A partial regression in cardiac hypertrophy was observed in the treated group. We suggest that the hypotensive response to ANF may be mainly due to vasodilatation, but the possibility that the decrease in PRA may play a partial role in lowering blood pressure, cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Garcı́a et al. (1985) studied Two-kidney, one-clip hypertension. Synthetic Atrial Natriuretic Factor (ANF 8-33) vs. Not treated hypertensive rats was evaluated on Blood pressure. Chronic infusion of synthetic ANF (8-33) in hypertensive rats decreased blood pressure from 183 +/- 4 mmHg to 116 +/- 5 mmHg and significantly lowered plasma renin activity.
Synapse has enriched 10 related papers. Consider them for comparative context: